Katy Milne

7.6k citations

55 papers · 4.9k indexed · 2 hit papers · h-index 31

Impact in

Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis

Papers in

Immunology 37
- Immune Cell Function and Interaction 22
- Immunotherapy and Immune Responses 21
- T-cell and B-cell Immunology 7
- Immune cells in cancer 5
Oncology 45
- Cancer Immunotherapy and Biomarkers 34
- CAR-T cell therapy research 13

Co-authors: Brad H. Nelson Peter H. Watson John R. Webb David R. Kroeger Ronald J. deLeeuw Sara E. Kost Julie S. Nielsen Nathaniel R. West
Journals: Clinical Cancer Research (9 papers)Gynecologic Oncology (4 papers)The Journal of Pathology (3 papers)Oncotarget (3 papers)OncoImmunology (3 papers)
Partner nations: Canada United States Denmark

In The Last Decade

Katy Milne

53 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers 2018 · 373 citations

Peers

Countries citing papers authored by Katy Milne

Since Specialization

Citations

This map shows the geographic impact of Katy Milne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Milne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Milne more than expected).

Fields of papers citing papers by Katy Milne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katy Milne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Milne. The network helps show where Katy Milne may publish in the future.

Co-authors

The 25 scholars most cited alongside Katy Milne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katy Milne Line = papers co-authored together Katy Milne links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Activated immune infiltrates expand opportunities for targeted therapy in p53‐abnormal endometrial carcinoma The Journal of Pathology ·Spencer D. Martin, Shelby Thornton, Christine S. Chow, Katy Milne, Juliana Sobral de Barros, Kayleigh Morris, Samuel Leung, Amy Jamieson, Brad H. Nelson, Dawn R. Cochrane, David G. Huntsman, C. Blake Gilks, Lien Hoang, Jessica N. McAlpine, Allen W. Zhang	2025	3
2	Polysialic acid is upregulated on activated immune cells and negatively regulates anticancer immune activity Frontiers in Oncology ·Olivia Drummond-Guy, J.M. Daly, Angeline Wu, Natalie Stewart, Katy Milne, Claire Duff, Brad H. Nelson, Karla C. Williams, Simon Wisnovsky	2025	1
3	VOLTA: an enVironment-aware cOntrastive ceLl represenTation leArning for histopathology Nature Communications ·Ramin Nakhli, Katherine Rich, Allen Zhang, Amirali Darbandsari, Elahe Shenasa, Amir Hadjifaradji, Sidney Thiessen, Katy Milne, Steven J.M. Jones, Jessica N. McAlpine, Brad H. Nelson, C. Blake Gilks, Hossein Farahani, Ali Bashashati	2024	4
4	Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer Clinical Cancer Research ·Céline M. Laumont, Maartje C.A. Wouters, Julian Smazynski, Nicole S. Gierc, Elizabeth A. Chavez, Lauren C. Chong, Shelby Thornton, Katy Milne, John R. Webb, Christian Steidl, Brad H. Nelson	2021	70
5	Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells Communications Biology ·Alyssa Vito, Omar Salem, Nader El-Sayes, Ian MacFawn, Ana L. Portillo, Katy Milne, Danielle Harrington, Ali A. Ashkar, Yonghong Wan, Samuel T. Workenhe, Brad H. Nelson, Tullia C. Bruno, Karen Mossman	2021	16
6	A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity Molecular Therapy — Oncolytics ·Joanne A. Hammill, Jacek M. Kwiecień, Anna Dvorkin‐Gheva, Vivian Wing Chong Lau, Christopher L. Baker, Ying Wu, Ksenia Bezverbnaya, Craig Aarts, Christopher W. Heslen, Galina Denisova, Heather Derocher, Katy Milne, Brad H. Nelson, Jonathan L. Bramson	2020	12
7	The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers Gynecologic Oncology ·Julian Smazynski, Phineas T. Hamilton, Shelby Thornton, Katy Milne, Maartje C.A. Wouters, John R. Webb, Brad H. Nelson	2020	26
8	Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma Clinical Cancer Research ·Aline Talhouk, Heather Derocher, Pascal Schmidt, Samuel Leung, Katy Milne, C. Blake Gilks, Michael S. Anglesio, Brad H. Nelson, Jessica N. McAlpine	2019	108
9	The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity Nature Communications ·Christopher W. Helsen, Joanne A. Hammill, Vivian Wing Chong Lau, Kenneth A. Mwawasi, Arya Afsahi, Ksenia Bezverbnaya, Lisa Newhook, Danielle L Hayes, Craig Aarts, Bojana Bojović, Galina Denisova, Jacek M. Kwiecień, Ian Brain, Heather Derocher, Katy Milne, Brad H. Nelson, Jonathan L. Bramson	2018	106
10	P2.01-065 Quantification of Tumor-Immune Cell Spatial Relationships in the Lung Tumor Microenvironment Using Single Cell Profiling Journal of Thoracic Oncology ·Katey S.S. Enfield, Sonia H.Y. Kung, Paul Gallagher, Katy Milne, Zhaoyang Chen, Daniela Piga, Stephen Lam, John C. English, Martial Guillaud, Calum MacAulay, Wan L. Lam	2017	2
11	CD103 and Intratumoral Immune Response in Breast Cancer Clinical Cancer Research ·Zhiqiang Wang, Katy Milne, Heather Derocher, John R. Webb, Brad H. Nelson, Peter H. Watson	2016	130
12	Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer Clinical Cancer Research ·David R. Kroeger, Katy Milne, Brad H. Nelson Hit paper breakdown →	2016	418
13	Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy Clinical Cancer Research ·Charlotte S. Lo, Sanaz Sanii, David R. Kroeger, Katy Milne, Aline Talhouk, Derek S. Chiu, Kurosh Rahimi, Patricia A. Shaw, Blaise Clarke, Brad H. Nelson	2016	128
14	Location, location, location OncoImmunology ·John R. Webb, Katy Milne, Brad H. Nelson	2014	39
15	Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer Clinical Cancer Research ·Darin A. Wick, John R. Webb, Julie S. Nielsen, Spencer D. Martin, David R. Kroeger, Katy Milne, Mauro Castellarin, Kwame Twumasi‐Boateng, Peter H. Watson, Robert A. Holt, Brad H. Nelson	2013	126
16	CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer Clinical Cancer Research ·Julie S. Nielsen, Rob A. Sahota, Katy Milne, Sara E. Kost, Nancy J. Nesslinger, Peter H. Watson, Brad H. Nelson	2012	418
17	BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma Modern Pathology ·Jessica N. McAlpine, Henry Porter, Martin Köbel, Brad H. Nelson, Leah Prentice, Steve E. Kalloger, Janine Senz, Katy Milne, Jiarui Ding, Sohrab P. Shah, David G. Huntsman, C. Blake Gilks	2012	129
18	Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer Breast Cancer Research ·Nathaniel R. West, Katy Milne, Pauline T. Truong, Nicol Macpherson, Brad H. Nelson, Peter H. Watson	2011	284
19	CD8+ T Cells Induce Complete Regression of Advanced Ovarian Cancers by an Interleukin (IL)-2/IL-15–Dependent Mechanism Clinical Cancer Research ·Taimei Yang, Erika M. Wall, Katy Milne, Patty Theiss, Peter H. Watson, Brad H. Nelson	2007	16
20	Spontaneous Mammary Tumors Differ Widely in Their Inherent Sensitivity to Adoptively Transferred T Cells Cancer Research ·Erika M. Wall, Katy Milne, Michele L. Martin, Peter H. Watson, Patty Theiss, Brad H. Nelson	2007	25

About Katy Milne

Katy Milne is a scholar working on Immunology, Oncology, Reproductive Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 55 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (34 papers), Immune Cell Function and Interaction (22 papers), Immunotherapy and Immune Responses (21 papers), CAR-T cell therapy research (13 papers), T-cell and B-cell Immunology (7 papers), Cancer Genomics and Diagnostics (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Immunology (3.1k citations), Oncology (3.6k citations), Reproductive Medicine (610 citations), Cancer Research (510 citations) and Obstetrics and Gynecology (148 citations). Katy Milne has collaborated with scholars based in Canada, United States and Denmark. Frequent co-authors include Brad H. Nelson, Peter H. Watson, John R. Webb, David R. Kroeger, Ronald J. deLeeuw, Sara E. Kost, Julie S. Nielsen, Nathaniel R. West, Zhiqiang Wang and Martin Köbel. Their work appears in journals such as Clinical Cancer Research, Gynecologic Oncology, The Journal of Pathology, Oncotarget and OncoImmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact